About Sequent Medical
Sequent Medical is a Healthcare company based in Aliso Viejo (United States) founded in 2007, and was acquired by Terumo Medical in June 2016. Catheter-based neurovascular devices for aneurysm treatment are developed. Sequent Medical has raised $65.26 million across 7 funding rounds from investors including HHS, Terumo Medical and Delphi Ventures. The company has 1,028 employees. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is MICROVENTION, INC. Its competitors include CoAxia and Metactive Medical; 2 of its 2 listed competitors have raised funding.
Company details
Sequent Medical was founded in 2007 as a privately held, development-stage company in the medical device sector. Catheter-based neurovascular technologies are developed, with the WEB Aneurysm Embolization System serving as the flagship implantable device for bridging aneurysms. CE Mark approval has been obtained in Europe, while US FDA approval remains pending. Operations are based in Aliso Viejo, United States.
- Headquarters Aliso Viejo, United States
- Employees 1,028
- Stage Acquired
- SectorsHealthcare
- Website sequentmedical.com
- Social LinkedIn
- Acquired by Terumo Medical (Jun 2016)
- Legal Name Microvention, Inc.
- Total Equity Funding$65.26M (USD)
in 7 rounds
- Latest Funding Round$1.05M (USD), Grant
Jun 2016
- InvestorsHHS
& 5 more
- Employee Count1,028
- Acquired byTerumo Medical
(Jun 2016)
Funding Insights of Sequent Medical
Sequent Medical has successfully raised a total of $65.26M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.05 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $65.26M
- Total Rounds 7
- Last Round Grant — $1.05M
- First Round $2.5M
(May 2009)
- Investors Count 5
All 7 funding rounds of Sequent Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $1.05M | Grant | – | – | |
| Apr 2014 | $20.1M | Series D | – | Delphi Ventures | |
| Mar 2012 | $26.04M | Series C | – | Delphi Ventures | |
| Aug 2011 | $261,353 | Grant | – | – | |
| May 2010 | $15.62M | Series B | – | Domain Associates, Versant Ventures | – |
| Mar 2010 | $1M | Series A | – | – | – |
| May 2009 | $2.5M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in Sequent Medical
Sequent Medical has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Terumo Medical and Delphi Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in life sciences firms across all stages. | delphiventures.com | Menlo Park, United States | ||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Portfolio of medical devices for interventional cardiology is provided. | 1921 | terumo.com | Somerset, United States |
Investor details for Sequent Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sequent Medical
28 people are tracked at Sequent Medical (15 in leadership, 13 in team); the tracked headcount is 1,028.
| Name | Role | Group |
|---|---|---|
Becca Bonwit | Director, Clinical Science And Data Integrity | Leadership |
Thierry De Bosson | Chief Commercial Officer | Leadership |
Carsten Schroeder | President & CEO | Leadership |
Kristin Machacek Leary | Chief People Officer | Leadership |
Terrence Callahan | Sr. Director Post Market Surveillance | Leadership |
Robert Gash | Sr. Director - Clinical Research & Operations (us And China) | Leadership |
Colin Kavanagh | Executive Vice President Of Operations | Leadership |
Laura Schiesl Vega | Associate General Counsel & Senior Director, Legal Affairs | Leadership |
Michelle Wetherby | Director Clinical Research And Operations | Leadership |
Patricia Sanchez | Senior Director, Human Resources | Leadership |
Dwayne Bess | Director Of Commercial Excellence | Leadership |
Doug Fauth | Sr. Director, Global Talent Acquisition & Development | Leadership |
Filipe Santos | Marketing Director - EMEA | Leadership |
James Marquis | Marketing Director | Leadership |
Alessandra Spina | Chief Compliance Officer | Leadership |
Wes L. | Senior Territory Sales Manager | Team |
Frank Louro | Market Development Manager | Team |
Tim Bowden | Territory Sales Manager | Team |
Jacqueline Collins | General Counsel | Team |
Nagesh Uppuluri | SVP, Global Clinical & Medical Affairs | Team |
8 more people are available in the full profile.
Complete people profiles for Sequent Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sequent Medical
4 dated milestones of Sequent Medical across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Sequent Medical is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Grant, of $1.1M.
- Exit Acquired by Terumo Medical.
Competitors of Sequent Medical
Sequent Medical has 2 listed competitors in our database, 2 of them funded. They include CoAxia and Metactive Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| coaxia.com | 1999 | Maple Grove, United States | $72.6M | Catheter-based treatment for cerebral ischemia | ||
| metactivemedical.com | 2011 | Olathe, United States | $4.7M | 31 | Endovascular devices are developed for peripheral and neurovascular disease treatments. |
Detailed competitors of Sequent Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Sequent Medical (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sequent Medical
Complete news archive for Sequent Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sequent Medical
Sequent Medical was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Sequent Medical is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.
Sequent Medical is a funded company, having raised a total of $65.26M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on May 2009.
Sequent Medical has 1,028 employees.
Sequent Medical was founded in 2007 as a privately held, development-stage company in the medical device sector. Catheter-based neurovascular technologies are developed, with the WEB Aneurysm Embolization System serving as the flagship implantable device for bridging aneurysms. CE Mark approval has been obtained in Europe, while US FDA approval remains pending. Operations are based in Aliso Viejo, United States.
Sequent Medical's top competitors include Metactive Medical and CoAxia.
Sequent Medical has 6 investors. Key investors include HHS, Terumo Medical, Delphi Ventures, Domain Associates, and USVP.
Sequent Medical operates through Microvention, Inc..
Yes. Sequent Medical was acquired by Terumo Medical in June 2016.